Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T.
Gäble A, Dierks A, Rinscheid A, Patt M, Wienand G, Pfob CH, Kircher M, Fukushima K, Nikolić AA, Enke JS, Janzen T, Steinestel J, Kempter H, Trepel M, Weckermann D, Lapa C, Bundschuh RA.
Gäble A, et al. Among authors: lapa c.
Eur J Nucl Med Mol Imaging. 2024 Nov 4. doi: 10.1007/s00259-024-06959-5. Online ahead of print.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 39489871